Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Fighting violent extremism – humanitarians beware
08/03/2017. Communities in some of the most dangerous corners of the world will be left without lifesaving aid because of countering violent extremism agendas. Millions of people living in countries facing famine may be hardest hit.
US foreign aid cuts: what could impact be?
04/28/2017. A leaked State Department budget document lays out proposals for a 30.8 percent cut in development aid and plans to sharply cut back.
Peacekeepers Shouldn’t Always Be Peaceful
04/19/2018. The United Nations needs to accept that it’s possible to fight and broker peace agreements at the same time.
